Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I. in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
Fox Chase Cancer Center /Inc/
Search grants from Fox Chase Cancer Center /Inc/
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Iron Trafficking and Regulation in Biological Systems
Rapid Induction of Therapeutic Hypothermia
Dissecting triazole resistance and transcriptional regulation of ergosterol homeo
Facility Management, Technical & Support Services
Myocardial Acid-Base Changes During Cpr
Recently added grants:
Unique Non-Saccharide Mimetics of Sulfated Glycosaminoglycan Target Colon Cancer Stem Cells
Reward processing and depressive subtypes: Identifying neural biotypes related to suicide risk, resilience, and treatment response
HPV alternative splicing in cervical cancer radiation response
Non-invasive, Transgene-free, on-demand Pharmacological Modulation of Neural Activity
Cholinergic Receptors in Aging and Early Alzheimer's Disease: Longitudinal Change
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025120-001
Application #
6994820
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center /Inc/
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2004
N01 CN
Phase I. in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center /Inc/
Comments
Be the first to comment on this grant